Sean Lybrand: Supporting Children with ALL with ACT 4 Children in Armenia
Sean Lybrand, Executive Director, Access to Healthcare at Amgen, shared a post on LinkedIn:
“This week Jon Hicks and I have been in Armenia at Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia on our first program visit with ACT 4 Children, a collaboration we entered in 2025 to focus on the healthcare needs of children living with acute lymphoblastic leukaemia.
Our support for the program is in collaboration with other organisations including City of Smile Charitable Foundation, Childhood Cancer International and Resonance, all of whom were present today in the engagements.
The photos attached are of the ‘survivor tree’ and ‘the bell’, rung when a child successfully completes there cancer treatment. Both are emotive symbols of success of cancer treatment- acknowledging that cancer survivors and their families also have ongoing needs for support that go well beyond their hospital time. The food photos are nutritional support programs provided by Childhood Cancer International to the children during their stay.
Thank you Yeolyan and our collaborators.”
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS